DE69625682D1 - Verfahren zur behandlung von entzündungen und zusammensetzungen dafür - Google Patents

Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Info

Publication number
DE69625682D1
DE69625682D1 DE69625682T DE69625682T DE69625682D1 DE 69625682 D1 DE69625682 D1 DE 69625682D1 DE 69625682 T DE69625682 T DE 69625682T DE 69625682 T DE69625682 T DE 69625682T DE 69625682 D1 DE69625682 D1 DE 69625682D1
Authority
DE
Germany
Prior art keywords
treating
serp
compositions
ignitions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625682T
Other languages
English (en)
Other versions
DE69625682T2 (de
Inventor
Grant Mcfadden
Alexandra Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viron Therapeutics Inc
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Publication of DE69625682D1 publication Critical patent/DE69625682D1/de
Application granted granted Critical
Publication of DE69625682T2 publication Critical patent/DE69625682T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
DE69625682T 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür Expired - Lifetime DE69625682T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/411,043 US5939525A (en) 1995-03-27 1995-03-27 Methods of treating inflammation and compositions therefor
PCT/US1996/004054 WO1996030042A2 (en) 1995-03-27 1996-03-26 Methods of treating inflammation and compositions therefor

Publications (2)

Publication Number Publication Date
DE69625682D1 true DE69625682D1 (de) 2003-02-13
DE69625682T2 DE69625682T2 (de) 2003-10-02

Family

ID=23627329

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625682T Expired - Lifetime DE69625682T2 (de) 1995-03-27 1996-03-26 Verfahren zur behandlung von entzündungen und zusammensetzungen dafür

Country Status (11)

Country Link
US (2) US5939525A (de)
EP (1) EP0817646B1 (de)
JP (1) JPH11503122A (de)
AT (1) ATE230609T1 (de)
AU (1) AU5323396A (de)
CA (1) CA2214988A1 (de)
DE (1) DE69625682T2 (de)
DK (1) DK0817646T3 (de)
ES (1) ES2187646T3 (de)
PT (1) PT817646E (de)
WO (1) WO1996030042A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
EP1223971B1 (de) 1999-10-27 2005-06-08 Alexandra Lucas Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AU1943501A (en) * 1999-12-02 2001-06-12 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
WO2001089449A2 (en) * 2000-05-25 2001-11-29 Ben Williger Phospholipase d effectors for therapy and screening
EP1365798B1 (de) * 2000-09-29 2009-12-30 Viron Therapeutics, Inc. Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
AU1174402A (en) * 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
ATE364625T1 (de) * 2000-12-04 2007-07-15 Viron Therapeutics Inc Proteine aus yaba monkey tumor virus mit modulatorischer aktivität
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
CA2440042C (en) * 2001-03-05 2011-09-27 Transtech Pharma, Inc. Carboxamide derivatives as therapeutic agents
US20030083305A1 (en) * 2001-10-10 2003-05-01 Peter Palese Viral interferon antagonists and uses therefor
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
AU2003280252A1 (en) * 2002-11-01 2004-05-25 Alexandra R. Lucas Viral serpin regulation of inflamation
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
WO1992006706A1 (en) * 1990-10-16 1992-04-30 John Lezdey Treatment of inflammation
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
CA2187444C (en) * 1994-04-08 2008-07-08 D. Grant Mcfadden Antirestenosis protein

Also Published As

Publication number Publication date
WO1996030042A3 (en) 1996-11-21
WO1996030042A2 (en) 1996-10-03
PT817646E (pt) 2003-04-30
ATE230609T1 (de) 2003-01-15
ES2187646T3 (es) 2003-06-16
DK0817646T3 (da) 2003-04-22
EP0817646A2 (de) 1998-01-14
EP0817646B1 (de) 2003-01-08
JPH11503122A (ja) 1999-03-23
DE69625682T2 (de) 2003-10-02
US5939525A (en) 1999-08-17
AU5323396A (en) 1996-10-16
CA2214988A1 (en) 1996-10-03
US5917014A (en) 1999-06-29

Similar Documents

Publication Publication Date Title
DE69625682T2 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69027865T2 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69835823D1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon
DE69703689T2 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
SE9603725D0 (sv) New teatment
IS5101A (is) Aðferðir við inngjöf efnasambanda sem eru mótefnigegn CD40L í sambandi við læknismeðferð
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69623316T2 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
DE69829995D1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
NO984198L (no) FremgangsmÕte for behandling av aggresjon
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
MY109685A (en) Method for treating hepatitis b carriers with minimal disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition